Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    cdc7
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated A Study of BMS-863233 in Patients With Hematologic Cancer
Condition: Refractory Hematologic Cancer
Intervention: Drug: Cdc7-inhibitor (BMS-863233)
2 Terminated A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
Conditions: Advanced Solid Cancers;   Metastatic Cancer
Intervention: Drug: Cdc7-inhibitor
3 Not yet recruiting A CR-UK Phase I Trial of LY3143921
Conditions: a. Colorectal Cancer;   b. High Grade Serous Ovarian Cancer;   c. Non Small-cell Lung Cancer (Squamous Cell Variant);   d. Squamous Carcinoma of the Oesophagus;   e. Squamous Carcinoma of the Head and Neck (HPV Negative);   f. Urothelial Cancer;   g. Breast Cancer (Triple Negative Type);   h. Pancreatic Cancer
Intervention: Drug: LY3143921 hydrate
4 Terminated Study of NMS-1116354 in Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: NMS-1116354
5 Terminated Study of NMS-1116354 in Advanced/Metastatic Solid Tumors
Condition: Advanced/Metastatic Solid Tumors
Intervention: Drug: NMS-1116354
6 Recruiting A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors
Condition: Nonhematologic Neoplasms, Advanced
Intervention: Drug: TAK-931

Study has passed its completion date and status has not been verified in more than two years.